Kala -Azar: Visceral Leishmaniasis (VL).


This document summarizes the problem of visceral leshmaniasis and describes the work of DNDi and its partners in developing new treatments: the search for new lead compounds, the preclinical development of new formulations of amphotericin B, and clinical trials of combination therapy in South Asia, Africa and Latin America.


4 pp.

Kala -Azar: Visceral Leishmaniasis (VL).

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.